NCT06468202

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2024-10-18Est. Completion: 2029-01-01

Enrollment target: 10,742 participants

Locations

University of Alabama at Birmingham, Birmingham, Alabama, United States
Cedars Sinai Medical Center, Los Angeles, California, United States
University of California, San Francisco, San Francisco, California, United States
Northwestern University, Chicago, Illinois, United States
Ochsner Baptist Medical Center, New Orleans, Louisiana, United States
University of Mississippi, Jackson, Mississippi, United States
University of New Mexico, Albuquerque, New Mexico, United States
Columbia University, New York, New York, United States
University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus, Ohio, United States
University of Pittsburg Magee, Pittsburgh, Pennsylvania, United States
Brown University, Providence, Rhode Island, United States
University of South Carolina Greenville, Greenville, South Carolina, United States
Austin Maternal Fetal Medicine, Austin, Texas, United States
Baylor College of Medicine, Houston, Texas, United States

Cardiovascular Health

This study will examine whether a patient navigation program can help improve long-term heart health among people who ex…

Boston, United StatesEst. completion Sep 2028

Hypertensive Disorder of PregnancyPreeclampsia

The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients wit…

Columbus, United StatesEst. completion Dec 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.